Boldenone undecylenate: better known as Equipoise or EQ: occupies a controversial place in AAS blood work. Users report anxiety, low libido, and high hematocrit, but the root causes are often misunderstood. The compound is not "toxic" in the way that orals or trenbolone are toxic. Instead, its effects on blood work are driven by a unique and paradoxical relationship with estrogen.
EQ also drives down SHBG more aggressively than most injectables. At 400 mg weekly, SHBG can drop 40-50% within 6 weeks. That raises free testosterone and free estradiol, which can mask the low-E2 effect on labwork. Your total E2 may read 30 pg/mL, but free E2 could be in the single digits. This is why some guys feel fine at a total E2 of 20 on testosterone alone, but feel terrible at the same number on EQ. If you are running EQ, ask for a free testosterone and free E2 panel, not just total. The free hormone picture explains more than the total.
The EQ/E2 paradox works like this: boldenone aromatizes to estrogen at about 50% of the rate of testosterone. This means, in theory, EQ should contribute less to estrogenic side effects than an equivalent dose of testosterone. But the metabolite boldenone has its own estrogenic activity: it binds to the estrogen receptor with weak affinity but at high enough concentrations can produce genuine estrogenic effects.
EQ Does Not Cause Low E2 by Itself
Understanding the EQ/E2 Paradox
The clinical presentation of EQ users is distinctive: they often report low E2 symptoms (joint pain, low libido, mood flattening) despite E2 levels that read as "normal" on standard labwork. This happens because EQ's metabolite, boldenone, competes with estradiol at the estrogen receptor. It binds with enough affinity to activate some estrogen signaling but not enough to produce full estradiol-like effects.
Standard immunoassay E2 tests can also overestimate true estradiol on EQ. Boldenone metabolites cross-react with many commercial E2 assays, inflating the reading by 10-20 pg/mL. So a result of 35 pg/mL on a standard test might actually be 20 pg/mL on LC-MS/MS. That is why the sensitive assay is worth insisting on when you're running EQ — a standard immunoassay result on its own is not a reliable basis for deciding anything, and it's better to get the LC-MS/MS number and bring it to whoever manages your protocol than to estimate a correction and act on the estimate.
The result is a situation where the estrogen receptor is partially occupied by a weak agonist (boldenone), leaving less room for the strong agonist (estradiol). The net effect is reduced estrogenic signaling despite normal estradiol levels. This is why EQ users can feel low-E2 even when their E2 blood work looks acceptable.
Why Testosterone Base Matters Here
Why EQ Causes Anxiety in Some Users
EQ-related anxiety is frequently attributed to the compound being "stimulating" or "aggressive." The real mechanism is more nuanced and more treatable. Anxiety on EQ typically has three contributors:
Low E2 Symptoms
Low estrogenic signaling causes anxiety, irritability, and emotional flattening in many men. This is not unique to EQ but is more common on EQ because of the boldenone metabolite effect described above. Check E2 before assuming the anxiety is psychological.
If your E2 is genuinely low, that's a finding worth bringing to whoever manages your protocol rather than adding something on your own — options like HCG or splitting testosterone injections into a more frequent schedule are the kind of adjustments that belong in that conversation, not a self-directed add-on. What's worth flagging clearly, though, is the direction of the mistake to avoid: reaching for an aromatase inhibitor when E2 is already low only compounds the problem, since it pushes E2 down further rather than addressing the actual shortfall.
High Hematocrit
Elevated hematocrit increases blood viscosity, which reduces cerebral blood flow and oxygen delivery. This produces a subtle but real sense of unease, brain fog, and anxiety. Many EQ users report improved mood after blood donation, which directly supports this mechanism.
Norepinephrine Effects
Boldenone and its metabolites may affect norepinephrine reuptake or receptor sensitivity. This produces a mild stimulant-like effect that some users experience as anxiety. This component is the hardest to manage and may not respond to E2 or hematocrit adjustments.
The practical approach: if you develop anxiety on EQ, check your E2 and hematocrit first. If hematocrit is high, donating blood and increasing hydration are safe steps you can take directly. If E2 is low, that's worth bringing to whoever manages your protocol rather than adjusting it yourself. If both come back normal and anxiety persists, you may simply be a poor candidate for boldenone.
If E2, hematocrit, and thyroid are all in range but anxiety persists, the norepinephrine effect described above is the likely culprit, and at that point supplement choices, dose adjustments, or switching compounds entirely are decisions worth making with whoever manages your protocol rather than experimenting alone. Stacking a stimulant like caffeine or a pre-workout on top tends to make things worse, not better. If boldenone turns out not to suit your neurochemistry, that's a legitimate reason to move to a different compound rather than push through it.
Hematocrit Management on Boldenone
Boldenone is one of the strongest stimulators of erythropoiesis in the AAS world. Its effect on hematocrit rivals Anadrol and exceeds most other injectable compounds. The mechanism is not fully understood but appears to involve both increased EPO production and direct bone marrow stimulation.
Hematocrit on EQ rises predictably and cumulatively. At 400-600 mg/week, most users will see a 5-8 point increase in hematocrit over 8-12 weeks. Some users reach 54-56% even at moderate doses, especially if they are dehydrated or have pre-disposition to elevated hematocrit.
Repeated blood donations deplete ferritin, and low ferritin causes its own set of problems: fatigue, restless legs, and poor recovery. If you are donating regularly to manage hematocrit, it's worth checking ferritin periodically alongside it and raising a low result with whoever manages your protocol rather than self-dosing iron — supplementing iron without a confirmed low ferritin can accelerate oxidative stress and worsen cardiovascular risk, which is exactly the kind of trade-off a bare number doesn't capture.
Why Hematocrit on EQ Deserves Close Attention
The Practical EQ Protocol
Here is how EQ's monitoring profile compares to testosterone's, for context on what to watch and why:
EQ vs. Testosterone: Side Effect Profile
| Marker | EQ (Boldenone) | Testosterone |
|---|---|---|
| E2 Impact | Complex — partial ER agonism via boldenone metabolite | Directly aromatizes to estradiol |
| Hematocrit Rise | Strong — 5-8 point increase typical | Moderate — 2-4 point increase typical |
| HDL Suppression | Moderate — 15-30% decrease | Mild — 10-20% decrease |
| Anxiety Potential | Significant in sensitive users | Low — usually E2-mediated |
| Key Monitoring | Hematocrit, E2 (sensitive), HDL | E2, hematocrit, prolactin |
The testosterone-to-EQ ratio, and the actual weekly doses of each, are protocol decisions for whoever manages the cycle, not a number to work out from a blood work article. What blood work can tell you is whether the ratio in use is producing the expected picture: check E2 with a sensitive (LC-MS/MS) assay a few weeks in, and if it's low despite what looks like an adequate testosterone base, that's a data point to bring back to whoever manages the protocol rather than a cue to adjust doses yourself. Hematocrit is worth checking on the same regular cadence and discussing any rise with them as well.
It's also worth monitoring hemoglobin and RBC count alongside hematocrit, since hematocrit can be artificially lowered or raised by hydration status while hemoglobin and RBC give a more stable picture of true erythrocytosis. A hemoglobin or RBC count that looks concerning even when hematocrit itself seems borderline is worth raising with whoever manages your protocol. Body composition also plays a role: EQ tends to raise hematocrit faster in people carrying more body fat, since adipose tissue produces inflammatory cytokines that stimulate EPO, so leaner athletes may see a slower rise. If a donation is made, it's worth rechecking hematocrit a couple of weeks later to see whether it actually held, since values can rebound quickly if the underlying drivers (hydration, activity, dose) haven't changed.